Satoris Neuro61 and Neuro77 Biomarker Panels

The Satoris Neuro61 and Neuro77 Biomarker Panels are configured for use in clinical research in neurodegenerative diseases, in particular Alzheimer’s disease and dementia. These two protein biomarker discovery panels have been optimized for markers associated with neuroinflammation and neurodegeneration and have been designed for researchers for identifying disease mechanisms and developing drug therapies. These two neurology focused panels are offered as a service exclusively through Satoris with sample processing provided by Rules-Based Medicine.
NeuroPanel61 Biomarker Panel
Satoris Part Ordering Number NPS-BA
|
|
|
NeuroPanel 77 Biomarker Panel
Satoris Part Ordering Number NPP-BA
Additional review of the literature identified 16 additional markers that were found to associated with AD . These supplementary markers from the literature have been incorporated in to the Neuro77 Biomarker panel in addition to those found on the Neuro61 Biomarker Panel.
|
|
|